摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[[7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]carbonyl]-4-phenyl-piperidine | 343241-14-5

中文名称
——
中文别名
——
英文名称
1-[[7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]carbonyl]-4-phenyl-piperidine
英文别名
[7-(3,4-Dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl]-(4-phenylpiperidin-1-yl)methanone;[7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl]-(4-phenylpiperidin-1-yl)methanone
1-[[7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]carbonyl]-4-phenyl-piperidine化学式
CAS
343241-14-5
化学式
C25H24Cl2N4O
mdl
——
分子量
467.398
InChiKey
VXJCSLJGHFPZQS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    32
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Heterocyclic dihydropyrimidine compounds
    申请人:——
    公开号:US20030022890A1
    公开(公告)日:2003-01-30
    Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the K v 1 subfamily of voltage gated K + channels, especially inhibitors K v 1.5 which has been linked to the ultra-rapidly activating delayed rectifier K + current I Kur ), methods of using such compounds in the prevention and treatment of arrhythmia and I Kur -associated conditions, and pharmaceutical compositions containing such compounds.
    本发明涉及一种新型杂环二氢嘧啶化合物,其可作为钾通道功能抑制剂(特别是Kv1亚家族电压门控K+通道的抑制剂,特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5的抑制剂),以及使用这些化合物在预防和治疗心律失常和IKur相关疾病方面的方法,以及含有这些化合物的药物组合物。
  • [EN] HETEROCYCLIC DIHYDROPYRIMIDINES AS POTASSIUM CHANNEL INHIBITORS<br/>[FR] DIHYDROPYRIMIDINES HETEROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DES CANAUX POTASSIUM
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2001040231A1
    公开(公告)日:2001-06-07
    Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors K¿v?1.5 which has been linked to the ultra-rapidly activating delayed rectifier K?+¿ current I¿Kur?), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    新型杂环二氢嘧啶化合物可作为钾通道功能抑制剂使用(特别是Kv1亚家族电压门控K+通道的抑制剂,特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5抑制剂),使用这种化合物预防和治疗心律失常和IKur相关疾病的方法,以及含有这种化合物的制药组合物。
  • HETEROCYCLIC DIHYDROPYRIMIDINES AS POTASSIUM CHANNEL INHIBITORS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP1237891A1
    公开(公告)日:2002-09-11
  • US6706720B2
    申请人:——
    公开号:US6706720B2
    公开(公告)日:2004-03-16
  • US7157451B2
    申请人:——
    公开号:US7157451B2
    公开(公告)日:2007-01-02
查看更多